Healthcare Sales & Marketing Network News: ion Pharmaceuticals

Searching News Database: ion Pharmaceuticals

HSMN NewsFeed - 15 Jul 2025
Tract Bio Appoints Chris Galloway, M.D., as Chief Medical and Development Officer and Expands Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2024
Sapience Therapeutics Strengthens Board of Directors and Management Team with Esteemed Business Development Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2024
Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 18 Mar 2024
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Feb 2024
Bexion Pharmaceuticals, Inc. Appoints Dr. Tariq Arshad as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 16 Feb 2024
Fusion Pharmaceuticals Enters into Exclusive Worldwide License Agreement with Heidelberg University and Euratom for Actinium-Based PSMA Targeted Radiotherapy
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 6 Nov 2023
NeuroBo Pharmaceuticals Strengthens Board of Directors with the Appointment of James P. Tursi, M.D.
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Dec 2022
Harm Reduction Therapeutics' New Drug Application for RiVive(TM) Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 3 Oct 2022
Alexion, AstraZeneca Rare Disease to Acquire LogicBio(R) Therapeutics to Accelerate Growth in Genomic Medicine
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Feb 2022
Avion Pharmaceuticals, LLC, an Alora Pharmaceuticals company, announces the FDA approval and availability of DHIVY(TM) for the treatment of Parkinson's disease
Biopharmaceuticals Neurology FDA Product Launch

HSMN NewsFeed - 10 Feb 2022
Ampio Expands Board of Directors with Addition of Elizabeth Varki Jobes
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Feb 2022
Bexion Pharmaceuticals Announces Leadership Additions
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Dec 2021
Nordic Nanovector appoints Experienced International Life Sciences Executive Sandra Jonsson as Chief Operating Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 23 Feb 2021
Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2021
Veteran Biopharma Executive Dane D. Hallberg Launches MASORI Therapeutics
Biopharmaceuticals

HSMN NewsFeed - 12 Nov 2020
Avion Pharmaceuticals, LLC, to Expand Its Women's Healthcare Portfolio of Products
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Jul 2020
ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 30 Jun 2020
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
Biopharmaceuticals Cardiology Generics Product Launch

HSMN NewsFeed - 1 Jun 2020
SwanBio Therapeutics Appoints Steven Zelenkofske, DO, as Chief Medical Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 7 May 2020
FogPharma Appoints Tony Gibney as Chief Financial Officer and Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Apr 2020
ANI Receives Refusal to File Letter from FDA for Cortrophin(R) Gel
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Apr 2020
ANI Announces Upcoming Departure of CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2020
ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin(R) Gel 80 U/mL
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Apr 2020
BioSpecifics Appoints Joseph Truitt as Interim Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Mar 2020
Leading Psychedelic Pharmaceutical Company MindMed Forms New Board Committee To Evaluate Acquisitions And Scientific Collaborations
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 2 Mar 2020
ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 3 Feb 2020
Portola Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jan 2020
ANI Announces Launch of Tolterodine Extended-Release Capsules
Biopharmaceuticals Urology Generics Product Launch

HSMN NewsFeed - 16 Jan 2020
ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 14 Jan 2020
ANI Announces Launch of Paliperidone Extended-Release Tablets
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 18 Dec 2019
ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL
Biopharmaceuticals Cardiology Product Launch

HSMN NewsFeed - 1 Oct 2019
Avidity Biosciences Appoints Sarah Boyce as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Sep 2019
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Sep 2019
Soligenix Appoints Jonathan Guarino as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jun 2019
ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc.
Biopharmaceuticals Generics Acquisitions

HSMN NewsFeed - 16 May 2019
Pulmatrix Announces Leadership Change
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 23 Apr 2019
Akero Therapeutics Appoints Industry Veteran Jane Pritchett Henderson to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2019
ANI Pharmaceuticals Announces Two Generic Product Launches
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 2 Jan 2019
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Dec 2018
Akero Therapeutics Appoints Mark Iwicki to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Oct 2018
ANI Announces Launch of Authorized Generic of Brethine(R)
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 2 Oct 2018
Titan Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 9 Aug 2018
Perrigo Announces Plan To Separate Prescription Pharmaceuticals Business
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 25 Jul 2018
Torque Appoints James Mullen as Chairman of Board of Directors, Maykin Ho, PhD, as Strategic Advisor to the Board of Directors, and Mario Sznol, MD, to Scientific Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Jun 2018
ANI Pharmaceuticals Announces Launch of Cholestyramine for Oral Suspension USP
Biopharmaceuticals Product Launch

HSMN NewsFeed - 21 Jun 2018
Alimera Sciences Appoints Mary T. Szela to its Board of Directors
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 15 May 2018
Medicinal Chemistry Leaders Drs. Phil Carpino and Mike Genin Form New Chemistry Team at Recursion Pharmaceuticals
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 May 2018
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
Biopharmaceuticals Generics Acquisitions

HSMN NewsFeed - 3 May 2018
CytRx Corporation Names Eric L. Curtis as Its President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 May 2018
Pharmaceutical Business Development Leader Dr. Kevin Lynch Joins Recursion as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Apr 2018
Actelion Submits Supplemental New Drug Application to US FDA Seeking Approval of OPSUMIT(R) (macitentan) for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Apr 2018
Amerigen and Dipharma Announce U.S. FDA Approval for Generic Miglustat 100 mg Capsules
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 2 Apr 2018
Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Feb 2018
Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 17 Jan 2018
Avion Pharmaceuticals announces approval of first NDA in the oral contraceptive category
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Jan 2018
Eiger BioPharmaceuticals Appoints David Apelian, MD, PhD, MBA Chief Operating Officer and Executive Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 21 Nov 2017
Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda(R) (Lurasidone Hydrochloride) in Europe
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 6 Sep 2017
Actelion Receives FDA Approval Of TRACLEER(R) (bosentan) For Use In Pediatric Patients With Pulmonary Arterial Hypertension
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Sep 2017
ANI Pharmaceuticals Announces Approval and Launch of Oxycodone Hydrochloride Oral Solution, 100 mg/5mL
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 20 Jun 2017
ANI Pharmaceuticals Announces Launch of Diphenoxylate HCl and Atropine Sulfate Tablets
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 14 Jun 2017
Eiger Announces Appointment of Biopharmaceutical Industry Veteran David Apelian, MD, PhD, MBA to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Apr 2017
Atara Bio Expands Management Team, Appoints Joe Newell as Executive Vice President, Chief Technical Operations Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Mar 2017
Novelion Therapeutics Appoints Mark Corrigan, M.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Feb 2017
ANI Pharmaceuticals Acquires Inderal(R) XL and InnoPran XL(R)
Biopharmaceuticals Cardiology Acquisitions

HSMN NewsFeed - 21 Feb 2017
Bristol-Myers Squibb Appoints Three New Independent Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2017
Vtesse Announces Appointment of Jason Meyenburg as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Dec 2016
Johnson & Johnson Announces it has Ended Discussions with Actelion
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Dec 2016
Novelion Therapeutics Subsidiary, Aegerion Pharmaceuticals, Enters Into Licensing Agreement With Amryt Pharma for LOJUXTA(R) (lomitapide)
Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 29 Nov 2016
Albireo Expands Team, Appoints Martha J. Carter as Chief Regulatory Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Oct 2016
ANI Pharmaceuticals Announces Launch of Benztropine Mesylate Tablets USP
Biopharmaceuticals Neurology Product Launch

HSMN NewsFeed - 8 Sep 2016
Albireo Appoints Dr. Paresh N. Soni as Chief Medical Officer
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 1 Sep 2016
Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Apr 2016
Avion Pharmaceuticals, LLC, announces appointment of new Chief Executive Officer
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 4 Apr 2016
ANI Pharmaceuticals Closes Acquisition of Inderal(R) LA Assets
Biopharmaceuticals Cardiology Acquisitions

HSMN NewsFeed - 31 Mar 2016
ContraVir Pharmaceuticals Appoints John Cavan as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Feb 2016
PhaseRx Strengthens Board of Directors and Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Dec 2015
Dr. Elizabeth Nabel Joins Moderna Therapeutics’ Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Dec 2015
Pulmatrix Appoints Mark Iwicki Chairman of the Board
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 10 Nov 2015
Seres Therapeutics Appoints Kurt Graves to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Nov 2015
Teva Canada Announces the Launch of PrTeva-Moxifloxacin Tablet, a generic of PrAvelox(R)
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 27 Oct 2015
CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 14 Oct 2015
Kura Oncology Appoints Thomas Malley to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Oct 2015
Quartet Medicine Completes $23.25 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 30 Jul 2015
Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jul 2015
BioSpecifics Announces Approval of XIAFLEX(R) in Japan for the Treatment of Dupuytren's Contracture
Biopharmaceuticals Regulatory

HSMN NewsFeed - 6 Jul 2015
Strensiq(R) (asfotase alfa) Receives Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia (HPP)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Jun 2015
Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jun 2015
Spero Completes $30 Million Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 27 May 2015
Zafgen Appoints Global Head of Medical Affairs and Global Head of Regulatory
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 May 2015
Clarus Ventures Promotes Michele Park, Ph.D., to Partner
Biopharmaceuticals Devices Venture Capital Personnel

HSMN NewsFeed - 18 Mar 2015
U.S. Food and Drug Administration Approves Cholbam for the Treatment of Rare Bile Acid Synthesis Disorders and Grants Rare Pediatric Disease Priority Review Voucher
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Mar 2015
Moderna Appoints Tal Zaks, Former Head of Sanofi Global Oncology, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 21 Jan 2015
Medivir Makes Change within the Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Sep 2014
WuXi PharmaTech Announces Appointment of William R. Keller to Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Aug 2014
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
Biopharmaceuticals Licensing

HSMN NewsFeed - 11 Aug 2014
Niklas Prager Appointed New President and CEO of Medivir
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Aug 2014
OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief Financial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 4 Aug 2014
RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Aug 2014
European Commission Grants Orphan Drug Designation to Soliris(R) (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 30 Jul 2014
Aegerion Pharmaceuticals Appoints Craig Fraser as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jul 2014
CutisPharma Appoints Neal Muni, MD, MSPH as President
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 May 2014
Third Rock Ventures and The Column Group Launch Nurix with $25.1 Million Financing to Target Key Regulatory Pathway
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 May 2014
Beryllium Launches and Expands Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 May 2014
Akorn to Acquire VersaPharm for $440 Million
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 5 May 2014
FDA Approves Conversion of Soliris(R) (eculizumab) Accelerated Approval in aHUS to Regular Approval for the Treatment of Patients with aHUS
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Apr 2014
Chugai Pharma USA Announces Appointment of Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Apr 2014
Dyax Corp. Announces Appointment of Todd Bazemore as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Mar 2014
Mike Sullivan named President of Avion Pharmaceuticals, LLC
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 28 Jan 2014
Veteran Biotech Executive David Arkowitz Joins Spring Bank Pharmaceuticals' Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jan 2014
Aegerion Pharmaceuticals' JUXTAPID(R) (lomitapide) Capsules Approved in Mexico for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 14 Jan 2014
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
Biopharmaceuticals Urology Gastroenterology Personnel

HSMN NewsFeed - 13 Jan 2014
Esperion Therapeutics Announces the Appointment of Antonio M. Gotto Jr., M.D., DPhil, as Director
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 7 Jan 2014
Cempra, Inc. Names David Moore as Chief Commercial Officer to Manage Commercial Development and Launch of Solithromycin and Taksta(TM)
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jan 2014
ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services
Biopharmaceuticals Generics

HSMN NewsFeed - 13 Dec 2013
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome Study of Collagenase Clostridium Histolyticum
Biopharmaceuticals Orthopaedic

HSMN NewsFeed - 6 Dec 2013
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(R) for the Treatment of Peyronie's Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Dec 2013
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 25 Nov 2013
Auxilium Pharmaceuticals Presented New Analyses of XIAFLEX(R) Peyronie's Disease Data at SMSNA Scientific Meeting
Biopharmaceuticals Urology

HSMN NewsFeed - 18 Nov 2013
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
Biopharmaceuticals

HSMN NewsFeed - 14 Nov 2013
Defibrotide Granted Orphan Drug Status in Australia
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Nov 2013
First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Oct 2013
Lorus Therapeutics Appoints New Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 22 Oct 2013
Neos Therapeutics, Inc. Announces the Appointment of Vipin K. Garg, Ph.D. as Chief Executive Officer and Board Director
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 11 Oct 2013
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA(TM) In The United States And Canada
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Oct 2013
Auxilium Pharmaceuticals, Inc. Presented Data At The ASSH Annual Meeting About XIAFLEX(R) For The Treatment Of Dupuytren's Contracture
Biopharmaceuticals Othopaedic

HSMN NewsFeed - 13 Sep 2013
Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Japan for All Patients with aHUS
Biopharmaceuticals Regulatory

HSMN NewsFeed - 12 Sep 2013
Cerecor Raises $6.8 Million in Series A-1 Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 28 Aug 2013
Auxilium Receives Notification of XIAFLEX(R) PDUFA Extension
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jul 2013
BioSante Hires VP of New Business Development and Contract Manufacturing and Announces New Appointment to Board of Directors
Biopharmaceuticals Generics Personnel

HSMN NewsFeed - 16 Jul 2013
Alexion’s Soliris(R) (eculizumab) Receives Positive Opinion from the Committee for Orphan Medicinal Products for Treatment of Neuromyelitis Optica (NMO)
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 28 Jun 2013
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 May 2013
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 15 May 2013
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 May 2013
Third Rock Ventures Expands and Strengthens Team
Biopharmaceuticals Devices Venture Capital Personnel

HSMN NewsFeed - 25 Apr 2013
Retrophin Names Horacio Plotkin, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Apr 2013
Alexion Broadens and Strengthens its Executive Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Apr 2013
NovaDel Announces the Signing of a Definitive Agreement to Sell its NovaMist(TM) Technology and Certain Other Assets
Biopharmaceuticals Drug Delivery Acquisitions

HSMN NewsFeed - 3 Apr 2013
Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 26 Feb 2013
Bausch & Lomb Names Robert Bertolini President And Chief Financial Officer
Devices Ophthalmology Personnel

HSMN NewsFeed - 8 Jan 2013
Absorption Pharmaceuticals Names Laurence A. Levine, MD As The Company's Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2013
Auxilium Pharmaceuticals, Inc. Announces Expansion of Its Exclusive License for XIAFLEX(R) (CCH) to Include the Potential Treatment of Cellulite as an Additional Indication
Biopharmaceuticals

HSMN NewsFeed - 28 Dec 2012
Perrigo Company Acquires Remaining Stake in Cobrek Pharmaceuticals, Inc. for Approximately $45 Million
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 27 Dec 2012
U.S. Food and Drug Administration Accepts XIAFLEX(R) Supplemental Biologics License Application Filing for the Treatment of Peyronie's Disease
Biopharmaceuticals Urology

HSMN NewsFeed - 18 Dec 2012
Blend Therapeutics Appoints Mark Iwicki as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Dec 2012
Diffusion Pharmaceuticals Receives FDA Orphan Designation for TSC, a First-in-Class Drug for the Treatment of Metastatic Brain Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 28 Nov 2012
Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2012
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Sep 2012
Insmed Appoints Will Lewis as President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 5 Sep 2012
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Sep 2012
Civitas Therapeutics Appoints Bryan E. Stuart Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 5 Sep 2012
Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX(R) Safety Update
Biopharmaceuticals

HSMN NewsFeed - 30 Aug 2012
Sunovion Pharmaceuticals Inc. to Acquire Elevation Pharmaceuticals, Inc.
Biopharmaceuticals Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 2 Aug 2012
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jul 2012
Cubist Pharmaceuticals Announces Senior Executive Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jun 2012
Actelion Pharmaceuticals Announces U.S. Food and Drug Administration Approval of Supplemental New Drug Application for Second Generation VELETRI(R) (epoprostenol) for Injection
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jun 2012
Theratechnologies Provides Regulatory Update on Tesamorelin
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Jun 2012
Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 6 Jun 2012
Achillion Announces Resignation of Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 May 2012
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim(R) in the U.S.
Biopharmaceuticals Urology

HSMN NewsFeed - 18 May 2012
Achillion Announces Executive Promotion
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 May 2012
New Executive Vice President Commercial Appointed
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Apr 2012
Avion Pharmaceuticals, LLC Names Michael Sullivan as new VP, Sales and Marketing
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 27 Mar 2012
Constellation Pharmaceuticals Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2012
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 23 Feb 2012
Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX(R) in Canada, Australia, Brazil and Mexico
Biopharmaceuticals

HSMN NewsFeed - 20 Jan 2012
NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 29 Nov 2011
Soliris(R) (eculizumab) Granted Marketing Authorization in Europe for Treatment of Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 17 Nov 2011
InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
Devices Interventional Personnel

HSMN NewsFeed - 25 Oct 2011
Aegerion Pharmaceuticals Appoints Craig E. Fraser as President, U.S.
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Sep 2011
Rib-X Announces Senior Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jul 2011
Diffusion Pharmaceuticals Receives FDA Orphan Status for TSC, a First-in-Class Drug for the Treatment of Primary Brain Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 21 Jul 2011
Aegerion Pharmaceuticals Announces Appointment of Paul G. Thomas to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jul 2011
Sequana Medical Receives CE Mark Approval for the ALFApump System and Adds Key Executive to Team
Devices Personnel

HSMN NewsFeed - 22 Jun 2011
Agennix Hires Jill Porter as Senior Vice President of Pharmaceutical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jun 2011
NovaDel Announces Changes in Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jun 2011
Constellation Pharmaceuticals Raises $15 Million in Additional Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 May 2011
Mylan to Rebrand Matrix Laboratories
Biopharmaceuticals

HSMN NewsFeed - 24 May 2011
Cerecor, Incorporated Initiates Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Apr 2011
Alexion Submits Applications for Soliris(R) (Eculizumab) as a Treatment for Patients with Atypical Hemolytic Uremic Syndrome (aHUS) in the United States and European Union
Biopharmaceuticals

HSMN NewsFeed - 15 Feb 2011
Aegerion Pharmaceuticals Appoints Diane L. Tribble, Ph.D., M.M.Sc., as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Feb 2011
Noven Appoints Lance D. Williams as Vice President of Human Resources
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Feb 2011
Aegerion Pharmaceuticals Appoints Martha J. Carter as Chief Regulatory Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Feb 2011
Zolpimist(TM) Oral Spray Launched in United States
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 2 Feb 2011
Amarin Corporation Appoints Industry Veteran Paul E. Huff as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Feb 2011
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Nov 2010
OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Nov 2010
DICOM Grid Secures $7.5 Million in Funding Led by Canaan Partners
Devices Radiology Venture Capital

HSMN NewsFeed - 1 Nov 2010
Vascular Pathways Inc. Completes Series B Financing
Devices Venture Capital

HSMN NewsFeed - 24 Sep 2010
Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex(R) Overactive Bladder Treatment for $400 Million in Cash
Biopharmaceuticals Urology Acquisitions

HSMN NewsFeed - 13 Sep 2010
OrbiMed Expands Private Equity Team
Venture Capital Personnel

HSMN NewsFeed - 13 Sep 2010
Third Rock Ventures Raises $426 Million Fund II
Venture Capital Personnel

HSMN NewsFeed - 13 Sep 2010
Aegerion Pharmaceuticals Appoints Marc Beer as CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Aug 2010
Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI(R) (epoprostenol for injection) for Pulmonary Arterial Hypertension
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Jul 2010
Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions

HSMN NewsFeed - 15 Jul 2010
Sepracor Inc. to Become Sunovion Pharmaceuticals Inc.
Biopharmaceuticals

HSMN NewsFeed - 3 Jun 2010
Trubion Pharmaceuticals Wins Genentech and Biogen Idec Patent Appeal
Biopharmaceuticals Litigation

HSMN NewsFeed - 2 Jun 2010
Constellation Pharmaceuticals Closes $22 Million in Series B Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 May 2010
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
Devices Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 Apr 2010
Actelion Pharmaceuticals Announces Commercial Availability of Epoprostenol for Injection for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals

HSMN NewsFeed - 16 Apr 2010
Alexion's Soliris(R) (Eculizumab) Receives Marketing Approval in Japan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Apr 2010
Perrigo and Partner Cobrek Announce Settlement of Luxiq(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 5 Apr 2010
Perrigo and Partner Cobrek Launch Generic Version of Evoclin(R) and Announce Settlement of Related Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 29 Mar 2010
Merck Serono: Erbitux Granted Extended Use in Japan for 1st-Line Treatment of mCRC Patients with KRAS Wild-Type Tumors
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Mar 2010
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Mar 2010
Omthera Pharmaceuticals, Inc. Closes a $6.5M Series A led by Sofinnova Partners to Advance Epanova, a Prescription Omega 3 Therapy
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 29 Jan 2010
Diffusion Pharmaceuticals LLC Closes on $5.9 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Jan 2010
Elevation Pharmaceuticals Raises $30 Million in Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Jan 2010
Constellation Pharmaceuticals Appoints Industry Veteran Garen Bohlin to Senior Management Group
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2010
Constellation Pharmaceuticals Appoints Kerry K. Reinertsen, Ph.D. as Company's Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Dec 2009
Vion Pharmaceuticals Announces FDA Conclusion
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 Dec 2009
Stockholders of CombinatoRx and Neuromed Vote for Merger
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 10 Dec 2009
Lundbeck Names Sean Nolan as New CEO of its Lundbeck Inc. U.S. Subsidiary
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Dec 2009
Alexion Appoints William R. Keller to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Nov 2009
NeurogesX Expands Commercial Operations Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Oct 2009
Perrigo Announces Dismissal of Duac(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 19 Oct 2009
Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Sep 2009
Perrigo Acquires ANDA for Generic Version Duac(R) Gel From KV Pharmaceutical
Biopharmaceuticals Generics Dermatology Acquisitions

HSMN NewsFeed - 9 Sep 2009
Constellation Pharmaceuticals Appoints Renowned Cancer Biologist Edward E. Harlow, Jr., Ph.D. as Company's CSO
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2009
Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Aug 2009
Constellation Pharmaceuticals, Inc. Appoints Mark A. Goldsmith, M.D., Ph.D. as CEO and Closes $17 Million in Funding
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 3 Aug 2009
Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 23 Jul 2009
Hisamitsu Pharmaceutical Co., Inc. Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 10 Jul 2009
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 2 Jul 2009
CombinatoRx and Neuromed Sign Merger Agreement
Biopharmaceuticals Mergers & Acquisitions Personnel

HSMN NewsFeed - 17 Jun 2009
Xanodyne Receives Approval From the U.S. Food and Drug Administration for ZIPSOR(TM) (diclofenac potassium) Liquid Filled Capsules
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Jun 2009
AssureRx Adds New CEO
Biopharmaceuticals Diagnostics Personnel

HSMN NewsFeed - 9 Jun 2009
Thallion Announces Changes to Management and Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jun 2009
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 May 2009
Emisphere Technologies Appoints Franklin M. Berger to Its Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 7 May 2009
Merck Serono Initiates SETTLE, the Second Phase III Clinical Trial of Safinamide in Advanced Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 5 May 2009
Merck Serono Launches Glucophage Powder in First European Countries
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 28 Apr 2009
Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show
Biopharmaceuticals

HSMN NewsFeed - 21 Apr 2009
Merck Serono Launches Kuvan(R) in Europe
Biopharmaceuticals

HSMN NewsFeed - 1 Apr 2009
Alexion Submits NDA in Japan for Soliris(R) (eculizumab) as a Treatment for Patients with PNH
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Mar 2009
Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 23 Mar 2009
Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 23 Mar 2009
Merck Serono Launches Strategic Venture Capital Fund
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Mar 2009
Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Mar 2009
Provenance Biopharmaceuticals Corp. Announces License Agreement with Merck Serono for the Development and Commercialization of Novel Immunocytokine for the Treatment of Cancer
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 17 Mar 2009
Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
Biopharmaceuticals Generics Litigation FDA

HSMN NewsFeed - 12 Mar 2009
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Feb 2009
Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Feb 2009
European Medicines Agency Recommends Suspension of Marketing Authorization for Raptiva(R)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 17 Feb 2009
Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
Biopharmaceuticals Licensing

HSMN NewsFeed - 3 Feb 2009
Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Jan 2009
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 23 Jan 2009
Merck Serono's Oral Investigational Treatment Cladribine Tablets for Multiple Sclerosis Significantly Reduced Relapse Rate in Two-Year Phase III Pivotal Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 13 Jan 2009
Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Jan 2009
FDA Advisory Committee Unanimously Recommends Sabril(R) (vigabatrin) for the Treatment of Two Catastrophic Epilepsies
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 5 Jan 2009
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Dec 2008
Perrigo Announces FDA Final Approval for Ibuprofen PM
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 9 Dec 2008
Merck Serono's Kuvan(R) Receives Marketing Authorization in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Dec 2008
Vion Pharmaceuticals Adds Tanya Lewis to Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Dec 2008
Cambridge Laboratories Announces Launch of XENAZINE(R) (Tetrabenazine) in the US
Biopharmaceuticals Neurology

HSMN NewsFeed - 13 Nov 2008
Perrigo Acquires Unico Holdings
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Sep 2008
Merck Serono's Kuvan(R) Recommended for European Approval
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Sep 2008
US Court Denies Teva's Motion for Summary Judgment in PULMICORT RESPULES(R) Patent Litigation
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 23 Sep 2008
Vyteris Announces Growth Initiative Through Expanded Business Development Team
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 22 Sep 2008
CytRx Corporation Completes Acquisition of Innovive Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 Sep 2008
Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 Sep 2008
Cambridge Laboratories Announces New Marketing Arrangements for XENAZINE(R) in North America
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Sep 2008
Perrigo Acquires Exclusive Sales and Distribution Rights to Allergy Drug Levocetirizine from Synthon
Biopharmaceuticals Generics Distribution

HSMN NewsFeed - 18 Aug 2008
Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Aug 2008
Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
Biopharmaceuticals

HSMN NewsFeed - 13 Aug 2008
Omeros Appoints David A. Mann to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jul 2008
Bristol-Myers Squibb and AstraZeneca Submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA(TM) (saxagliptin) for the Treatment of Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology

HSMN NewsFeed - 17 Jul 2008
Vertos Medical Inc. Completes Series C Financing
Devices Neurosurgery Orthopaedic Venture Capital

HSMN NewsFeed - 11 Jul 2008
Perrigo Company Announces Appointment of New Board Member
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jul 2008
Agios Pharmaceuticals Closes $33 Million Series A Funding
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 23 Jun 2008
OVATION Pharmaceuticals to In-License ATryn(R) (antithrombin alfa) in the United States
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Jun 2008
Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
Biopharmaceuticals

HSMN NewsFeed - 10 Jun 2008
Merck Serono Strengthens its Prescription Medicines Portfolio in Latin America
Biopharmaceuticals Distribution

HSMN NewsFeed - 10 Jun 2008
Merck Serono's Rebif(R) Celebrates 10th Anniversary
BIopharmaceuticals Neurology

HSMN NewsFeed - 9 Jun 2008
CytRx Corporation Signs Definitive Agreement to Acquire Innovive Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Jun 2008
Merck Serono Announces Initiation of Second Phase II/III Clinical Study of Atacicept in Lupus
Biopharmaceuticals

HSMN NewsFeed - 2 Jun 2008
Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 May 2008
Endo Pharmaceuticals Appoints Blaine T. Davis as Vice President, Investor Relations and Corporate Communications
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 May 2008
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 May 2008
KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 6 May 2008
Rib-X Pharmaceuticals, Inc. Appoints Nancy Motola as Senior Vice President of Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 May 2008
Unique Three-Year Data Demonstrating Long-Term Efficacy and Safety of Raptiva(R) in the Treatment of Psoriasis Published in the British Journal of Dermatology
Biopharmaceuticals

HSMN NewsFeed - 29 Apr 2008
Constellation Pharmaceuticals Closes $32 Million in Series A Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 24 Apr 2008
Transdel Pharmaceuticals Appoints Chief Medical Officer and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Apr 2008
Merck Announces Planned Investment of $50 Million in Research Center in the US
Biopharmaceuticals

HSMN NewsFeed - 15 Apr 2008
Anaphore, Inc Receives $8M Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 11 Apr 2008
Endo Announces Executive Appointment
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Apr 2008
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
Biopharmaceuticals

HSMN NewsFeed - 31 Mar 2008
First Statin Monotherapy to Achieve Regression of Coronary Atherosclerosis by Angiography in a Major Clinical Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 20 Mar 2008
Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan

HSMN NewsFeed - 19 Mar 2008
Icagen Announces Senior Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2008
Merck Serono Launches Cyanokit(R) in Japan
Biopharmaceuticals

HSMN NewsFeed - 12 Mar 2008
Endo Pharmaceuticals Names David P. Holveck President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Mar 2008
Complete Care Medical Announces Proprietary Catheter and Insertion Kit
Devices Urology

HSMN NewsFeed - 27 Feb 2008
FDA Accepts for Review OVATION's Two NDA Submissions for Sabril(R)
Biopharmaceuticals Neurology

HSMN NewsFeed - 27 Feb 2008
OVATION Appoints Christopher Silber, M.D. as Vice President, Clinical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Feb 2008
Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment
Biopharmaceuticals Licensing

HSMN NewsFeed - 14 Feb 2008
Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
Biopharmaceuticals

HSMN NewsFeed - 4 Feb 2008
Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jan 2008
Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Jan 2008
Reckitt Benckiser Announces Completion of Cash Tender Offer for All Outstanding Shares of Adams Respiratory Therapeutics, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 15 Jan 2008
First Head to Head Study Comparing Crestor(TM) and Lipitor(R) Effects on the Treatment of Atherosclerosis
Biopharmaceuticals Cardiology

HSMN NewsFeed - 8 Jan 2008
Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Jan 2008
Reckitt Benckiser Receives Hart-Scott-Rodino Antitrust Clearance for Acquisition of Adams Respiratory Therapeutics
Devices Mergers & Acquisitions

HSMN NewsFeed - 3 Jan 2008
Orphan Drug Designation Granted to OVATION's Clobazam for the Adjunctive Treatment of a Severe Form of Childhood Epilepsy
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 28 Dec 2007
Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 11 Dec 2007
PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
Biopharmaceuticals

HSMN NewsFeed - 10 Dec 2007
FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
Biopharmaceuticals

HSMN NewsFeed - 10 Dec 2007
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
Biopharmaceuticals

HSMN NewsFeed - 10 Dec 2007
Acquisition of Adams Respiratory Therapeutics by Reckitt Benckiser
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Dec 2007
Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
Biopharmaceuticals

HSMN NewsFeed - 27 Nov 2007
BIND Biosciences, Inc. Closes $16M Series B Financing Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Nov 2007
Achillion Announces Appointment of New Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Nov 2007
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Nov 2007
AstraZeneca Appoints Kenneth L. Murtha as Regional Supply VP for the Americas
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Nov 2007
CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol
Biopharmaceuticals FDA Cardiology

HSMN NewsFeed - 7 Nov 2007
New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Nov 2007
New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure
Biopharmaceuticals Cardiology

HSMN NewsFeed - 1 Nov 2007
Perrigo Announces that Dexcel's Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 31 Oct 2007
Perrigo Elevates Joseph C. Papa to Chairman of the Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Oct 2007
Taisho and Pfizer Sign a Letter of Intent for Taisho's Schizophrenia Drug Candidate
Biopharmaceuticals

HSMN NewsFeed - 29 Oct 2007
Thallion Provides Update on Shigamabs(R) Clinical Development and U.S. Regulatory Plan
Biopharmaceuticals

HSMN NewsFeed - 29 Oct 2007
Adams Respiratory Therapeutics Receives Approvable Letter From FDA for Mucinex(R) With Codeine
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Oct 2007
Allozyne, Inc., Closes $30 Million Series B Financing and Appoints Meenu Chhabra as President and Chief Executive Officer
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 23 Oct 2007
Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension
Biopharmaceuticals

HSMN NewsFeed - 16 Oct 2007
Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 9 Oct 2007
Optherion, Inc. Completes $37 Million Start Up Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 3 Oct 2007
Prism Pharmaceuticals Appoints Maurits Geerlings Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2007
Pediatric Asthma Programs With CyDex Captisol Technology Acquired by AstraZeneca
Biopharmaceuticals Drug Delivery Acquisitions

HSMN NewsFeed - 27 Sep 2007
Adams Respiratory Therapeutics Files Lawsuit Against Perrigo for Infringement of Mucinex(R) Patent
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 27 Sep 2007
BrainCells Inc., Taisho Pharmaceutical Co., Ltd. Sign Licensing Agreement for Novel CNS Program
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 24 Sep 2007
Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Sep 2007
Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Biopharmacetuicals Oncology

HSMN NewsFeed - 19 Sep 2007
Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 13 Sep 2007
Perrigo Vice Chair Mori Arkin To Retire After 30 Years of Service
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Sep 2007
New Data On Orexin Receptor Antagonist Almorexant Shows Therapeutic Potential to Restore Normal Physiological Sleep in Patients Suffering From Insomnia
Biopharmaceuticals

HSMN NewsFeed - 31 Aug 2007
Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
Biopharmaceuticals

HSMN NewsFeed - 20 Aug 2007
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Biopharmaceuticals

HSMN NewsFeed - 4 Jul 2007
Circassia Announces the Appointment of Sir Richard Sykes as Chairman of the Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jun 2007
AstraZeneca Announces SYMBICORT(R) is Now Available in the U.S.
Biopharmaceuticals

HSMN NewsFeed - 22 Jun 2007
Alexion's Soliris(TM) Granted Marketing Approval in Europe for Treatment of All Patients With PNH
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Jun 2007
NanoMed Pharmaceuticals Hires Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jun 2007
Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Jun 2007
CombinatoRx and Angiotech Extend Research and Development Collaboration to Create Next Generation Drug Device and Local Delivery Medicines
Devices Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 11 Jun 2007
Studies Show Efficacy and Safety of Alexion's Soliris(TM) in Broad Population of PNH Patients
Biopharmaceuticals

HSMN NewsFeed - 6 Jun 2007
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Jun 2007
Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Jun 2007
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Jun 2007
Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II trial of Cloretazine(R) (VNP40101M) in Patients with Relapsed or Refractory Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jun 2007
Next Generation of Investigational Anti-Cancer Agents Unveiled at ASCO by AstraZeneca
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 May 2007
Peplin Appoints Chief Commercial Officer
Biopharmaceuticals Dermatology Oncology Personnel

HSMN NewsFeed - 23 May 2007
Vion Announces Suspension of Phase III Trial in Relapsed AML
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 May 2007
FDA Approves Astrazeneca's Once-Daily Seroquel XR(TM) Extended-Release Tablets for the Treatment of Schizophrenia
Biopharmaceuticals FDA

HSMN NewsFeed - 17 May 2007
Achillion Announces the Resignation of John C. Pottage, Jr., M.D., Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 May 2007
Achillion Appoints OSI Executive Robert Van Nostrand to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 May 2007
AstraZeneca to Begin Construction for $100M Research Investment at R&D Boston; Expansion Solidifies Company's Commitment to Massachusetts as a Scientific and Biotech Hub
Biopharmaceuticals

HSMN NewsFeed - 27 Apr 2007
CHMP Adopts Positive Opinion for Alexion's Soliris(TM) in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 26 Apr 2007
Diffusion Pharmaceuticals Announces Formation of Scientific Advisory Board Chaired by Company Co-founder, John L. Gainer, Ph.D.
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Apr 2007
Adams Respiratory Therapeutics Adds Two New Board Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Apr 2007
Thallion Pharmaceuticals Inc. Hires Executive Vice-President, Licensing and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Apr 2007
Thallion Presents Data at the 2007 Annual Meeting of the American Association of Cancer Research on its Oncology Drug Candidates ECO-4601 and CAP-232
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Apr 2007
Dr. James Tanguay Joins Vion Pharmaceuticals' Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Apr 2007
PDL BioPharma Announces Election of L. Patrick Gage as Chairman of the Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Apr 2007
Adams Respiratory Therapeutics Highlights the Expansion and Diversification of its Product Portfolio
Biopharmaceuticals

HSMN NewsFeed - 28 Mar 2007
Rincon Pharmaceuticals Appoints Dr. Peter B. Heifetz as Chief Scientific Officer, Drs. Jacqueline J. Johnson and Alan J. Lewis to Board of Directors, and Drs. Katherine S. Bowdish and Mich B. Hein to Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2007
Adams Respiratory Therapeutics Enters Into License and Collaboration Agreement With MonoSol Rx, LLC
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 21 Mar 2007
Adams Respiratory Therapeutics Enters Into Settlement Agreement With Mutual Pharmaceutical
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 19 Mar 2007
Update: FDA Approves Alexion's Soliris(TM) for All Patients With PNH
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Mar 2007
Diffusion Pharmaceuticals Initiates Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC)
Biopharmaceuticals

HSMN NewsFeed - 16 Mar 2007
FDA Approves Alexion's Soliris(TM) for All Patients With PNH
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Mar 2007
Actelion: Positive Study With Bosentan (Tracleer) in CTEPH
Biopharmaceuticals

HSMN NewsFeed - 26 Feb 2007
AstraZeneca Announces New Phase III Study of Vandetanib (ZACTIMA(R), ZD6474) in Patients With Advanced Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Feb 2007
Panacos Appoints Dr. Tom Lategan, Vice President of Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Feb 2007
Adams Respiratory Therapeutics Announces Promotion of Rita M. O'Connor to Chief Financial Officer and Treasurer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Feb 2007
Adams Respiratory Therapeutics Announces Resignation of Chief Financial and Administrative Officer and Treasurer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Feb 2007
AstraZeneca Licenses Regeneron's VelocImmune(R) Technology for Discovering Human Monoclonal Antibodies
Biopharmaceuticals Licensing

HSMN NewsFeed - 5 Feb 2007
Successful Proof-of-Concept With Actelion's Orexin Receptor Antagonist in Patients Suffering From Primary Insomnia -- First Demonstration of Key Role of Orexin System in Humans Suffering From Sleep Disorders
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2007
Ivrea Pharmaceuticals Appoints Daniel S. Lynch as President and Chief Executive Officer
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2007
AstraZeneca Acquires Arrow Therapeutics To Broaden Anti-Infective Capabilities
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Jan 2007
CombinatoRx Announces Senior Management Updates
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jan 2007
Harold F. Oberkfell Succeeds Steven A. Elms as Chairman of Adams Respiratory Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jan 2007
Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to Develop and Commercialize Diabetes Compounds
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 10 Jan 2007
New England Journal of Medicine Reports Aegerion's Lead Compound Reduces LDL By 51% in Patients With a Severe Form of Hypercholesterolemia
Biopharmaceuticals Cardiology

HSMN NewsFeed - 4 Jan 2007
Ecopia Announces Agreement with Caprion to Combine their Businesses and Launch a $30 Million Private Placement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Dec 2006
Targacept to Receive $20 Million Milestone Payment as AstraZeneca Plans to Continue Development of AZD3480 (TC-1734)
Biopharmaceuticals Neurology

HSMN NewsFeed - 13 Dec 2006
Vion Pharmaceuticals Enters Into Manufacturing Agreement for Cloretazine(R) (VNP40101M) With Ben Venue Laboratories
Biopharmaceuticals

HSMN NewsFeed - 11 Dec 2006
Eculizumab is Well Tolerated and Demonstrates Significant Improvement During 52 Weeks of Treatment in Open-Label Phase III SHEPHERD Study in PNH Patients
Biopharmaceuticals

HSMN NewsFeed - 4 Dec 2006
Phase II Data Shows Ovation's Novel Compound Clobazam to Be Well Tolerated in Patients With Catastrophic Epilepsy
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 Dec 2006
AstraZeneca's Statement on the Cost-Effectiveness Findings of the Clinical Antipsychotic Trials of Intervention Effectiveness-Schizophrenia (CATIE-SZ)
Biopharmaceuticals

HSMN NewsFeed - 21 Nov 2006
AstraZeneca Announces Distribution Agreement With Par Pharmaceutical for an Authorized Generic Version of TOPROL-XL(R)
Biopharmaceuticals Generics Distribution

HSMN NewsFeed - 15 Nov 2006
ARIUS appoints Warren Whitehead as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Nov 2006
Diffusion Pharmaceuticals Strengthens Management Team With Appointment of Matthew W. Hantzmon as Vice President, Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Nov 2006
FDA Grants Priority Review for Soliris(TM) (eculizumab) BLA for Treatment of Paroxysmal Nocturnal Hemoglobinuria
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Nov 2006
Approved Asthma Therapy SYMBICORT Improves Lung Function Safely and Effectively
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2006
Once- or Twice-Daily Treatment With PULMICORT RESPULES(R) (budesonide inhalation suspension) Significantly Increased Percentage of Days Asthma Is Controlled
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2006
Vion Pharmaceuticals Reaches Midpoint of Patient Accrual to Cloretazine(R) (VNP40101M) Phase III Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Nov 2006
AstraZeneca Appoints Howard Hutchinson as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Oct 2006
Adams Respiratory Therapeutics Announces Organizational Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Oct 2006
Vion Pharmaceuticals Presents Initial Data From a Phase II Trial of Cloretazine(R) (VNP40101M) in Patients With Relapsed or Refractory Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Oct 2006
Caprion Pharmaceuticals Announces Expansion of Biomarker Discovery Collaboration with Vertex Pharmaceuticals
Biopharmaceuticals

HSMN NewsFeed - 24 Oct 2006
FDA Approves New Formulation for NEXIUM
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 20 Oct 2006
FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Oct 2006
FDA Approves NEXIUM for the Treatment of Zollinger-Ellison Syndrome
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 2 Oct 2006
Adams Respiratory Therapeutics Files Lawsuit Against Mutual Pharmaceuticals and United Research Laboratories for Infringement of Mucinex(R) Patent
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 27 Sep 2006
Trubion Announces Initiation of Phase IIb Clinical Trial of TRU-015 for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 26 Sep 2006
Alexion Submits Market Authorization Application for Soliris(TM) (eculizumab) in the Treatment of Paroxysmal Nocturnal Hemoglobinuria to the European Medicines Agency
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 Sep 2006
Schering AG and AstraZeneca Form Strategic Alliance to Develop Novel Anti-Cancer Drug
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Sep 2006
Chugai Announces Co-Development and Co-Marketing Agreement with Taisho Pharmaceutical for the Antiresorptive Bisphosphonate R484
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Sep 2006
Dynavax Establishes Collaboration for TLR-9 Agonists for Asthma and COPD With AstraZeneca
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Sep 2006
OVATION and Cardinal Health Announce FDA Approval Letter for Manufacturing of Biologic Therapy To Treat Rare Genetic Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Jul 2006
OVATION Pharmaceuticals Announces First New Drug Treatment in 20 Years for Premature Infants with Patent Ductus Arteriosus
Biopharmaceuticals Cardiology

HSMN NewsFeed - 19 Jul 2006
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Mobic(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 18 Jul 2006
AstraZeneca Submits NDA for Sustained Release Formulation of SEROQUEL(R) for Schizophrenia Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Jul 2006
Aileen Ryan Joins Vion Pharmaceuticals' Senior Management Team
Biopharmaceuticals

HSMN NewsFeed - 13 Jul 2006
Alexion Pharmaceuticals Purchases Biopharmaceutical Manufacturing Site in Rhode Island
Biopharmaceuticals

HSMN NewsFeed - 12 Jul 2006
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Glucotrol(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 11 Jul 2006
Procter & Gamble Pharmaceuticals and ARYx Therapeutics Form Alliance for an Investigational Treatment for Gastrointestinal Disorders
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 6 Jul 2006
Alexion Pharmaceuticals Appoints David L. Hallal Vice President U.S. Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jun 2006
Abraxis BioScience Completes Acquisition of the AstraZeneca U.S. Branded Anesthetic and Analgesic Product Lines
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 22 Jun 2006
New Data Shows CRESTOR(R) Helped African American, Hispanic American and South Asian American Patients Significantly Lower LDL-C and Achieve Cholesterol Goals
Biopharmaceuticals Cardiology

HSMN NewsFeed - 22 Jun 2006
Adams Respiratory Therapeutics Announces Resignation of Andrew N. Schiff, M.D. from Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 May 2006
Vion Pharmaceuticals Provides Update for Clinical and Preclinical Programs
Biopharmaceuticals

HSMN NewsFeed - 29 May 2006
Zecotek Medical Systems announces new management, scientific advisory board appointments, and website release
Devices Personnel

HSMN NewsFeed - 25 May 2006
UCB Sells to Adams Respiratory Therapeutics OTC Delsym(R) 12-Hour Cough Suppressant Liquids
Biopharmaceuticals Licensing

HSMN NewsFeed - 24 May 2006
Vion Initiates Pivotal Phase II Trial of Single Agent Cloretazine(R) in Elderly Patients with De Novo Poor-Risk Acute Myelogenous Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 May 2006
Second Investigational Study of SEROQUEL(R) in the Treatment of Depressive Episodes Associated with Bipolar Disorder Confirms Previous Findings
Biopharmaceuticals

HSMN NewsFeed - 22 May 2006
New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
Biopharmaceuticals

HSMN NewsFeed - 22 May 2006
Study Investigates NEXIUM(R) Benefits Patients With Zollinger-Ellison Syndrome
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 22 May 2006
New Study Shows Erosive Esophagitis Healing Linked to Gastric Acid Control
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 19 May 2006
Targacept Announces Positive Phase II Results for TC-1734 (AZD3480) in Memory Impaired Older Subjects
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 May 2006
New Phase III Data on Renin Inhibitor SPP100 (Rasilez) in Treatment of Hypertension Demonstrates Potential of This First-in-Class Drug
Biopharmaceuticals

HSMN NewsFeed - 15 May 2006
CRESTOR Helped More Patients Reach Goal in MERCURY II Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 4 May 2006
Combined Use of ATACAND(R) (candesartan cilexetil) and ACE Inhibitor Improves Heart Failure Outcomes More Than ACE Inhibitor Alone
Biopharmaceuticals Cardiology

Return to NewsFeed

Additional items found! 309

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 309 additional stories matching:
ion Pharmaceuticals
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!